Written by Abhishek De | New Delhi | Updated: December 20, 2020 7:47:28 pm Swab collection for ongoing Covid-19 testing inside an NMMC mobile testing facility in Vashi (Express photo by Amit Chakravarty) The United States was shot in the arm in its fight against Covid-19 after the Food and …
Read More »Doctors, MBBS students among 30 million people who will receive the Covid-19 vaccine first, Aadhaar is not required
As Bharat Biotech aims to launch its vaccine, Covaxin, in February, which could be the first vaccine available in India, the Center is finalizing the procedure for administering the vaccine, including identifying the priority groups to target. they will administer the vaccine first and at no cost. . The group …
Read More »Moderna and Pfizer aim to deliver vaccine by December
Written by Abhishek De, edited by Explained Desk | New Delhi | Updated: October 29, 2020 12:09:08 am A healthcare worker takes a nasal swab sample at a COVID-19 testing center in Hyderabad (AP) With the results of late-stage clinical trials by two Covid-19 vaccine pioneers, Moderna Inc and Pfizer, …
Read More »Covid-19 vaccine: healthy young people may have to wait until 2022, says WHO
The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »COVID-19 vaccine by the end of this year? Oxford on the brink of one, says British prime minister
Will the world have another ‘safe and effective’ vaccine against the new coronavirus later this year? UK Prime Minister Boris Johnson is hopeful. Commenting on the progress of the COVID-19 vaccine, Johnson said Monday that he felt an AstraZeneca project should be on the brink of one. “I went to …
Read More »Covid-19: how nasal, single injection and passive vaccines work
In the ongoing race for an effective Covid-19 vaccine, several pharmaceutical companies are exploring out of the ordinary places. Johnson & Johnson is testing a single-shot vaccine, while traditional vaccine candidates require two injections. Bharat Biotech has announced the manufacture of an intranasal vaccine, which will differentiate it from intramuscular …
Read More »Covid-19 Vaccine: When Will the U.S. Get Its First Vaccine? – world News
When Johnson & Johnson announced the third phase of its Covid-19 vaccine clinical trial, US President Donald Trump said that four Covid-19 vaccine candidates are in the final stage. Here is the status of the ongoing trials Pfizer The candidate vaccine being developed by Pfizer and its German partner BioNTech …
Read More »Serum Institute to Resume Trial in India After DCGI Approval
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »Astrazeneca gets regulator go-ahead to resume Oxford vaccine trial in UK
British-Swedish firm Astrazeneca said it had resumed testing of the coronavirus vaccine from the University of Oxford in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a …
Read More »